Pacira Pharmaceuticals Inc recalls Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Stability Specifications - at 12 months 2-8 degrees C followed by 6 weeks at 25 degrees C.
- Products
-
- Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension)
- Company
- Pacira Pharmaceuticals Inc
- Where it was sold
-
U.S. Nationwide.
Nationwide
- Units affected
- 43,768 kits
- About this recall
- Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-001-01. Diluent Vial Label: Diluent, 5mL, Sterile single use, Rx only, Manufactured for Pacira Pharmaceuticals Inc., NDC 65250-002-01. Carton Label: Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-003-01.